Patents by Inventor Lina Yin
Lina Yin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240390791Abstract: This application disclose a feature extraction method performed by a computer device. The method includes: shooting a cone-shaped group of viewing-frustum rays from a target character object for a hit object in a three-dimensional scene picture; determining object attribute information of the hit object based on an interaction between the viewing-frustum rays and the hit object; performing vector conversion on the object attribute information of the hit object, to obtain a ray-feature vector; collecting, by using a location of the target character object as a collection center, a plurality of height-value matrices corresponding to different granularities; performing feature dimension reduction on the height-value matrix corresponding to each granularity, to obtain a height-map feature vector; and integrating the ray-feature vector and the height-map feature vector into a three-dimensional scene feature.Type: ApplicationFiled: August 5, 2024Publication date: November 28, 2024Inventors: Zhipeng XU, Jingwen YANG, Xiaoxi WANG, Zihui GU, Le WAN, Jun YIN, Zhuoneng OUYANG, Dingjian JIN, Mingxiang LIAO, Zongbo LIU, Yuning LIANG, Bingquan GUAN, Yihao YANG, Jiazhong SHEN, Siliang LIU, Lina GAO
-
Patent number: 12037908Abstract: A method for monitoring and analyzing large tunnel machines based on automatic collection of big data includes the following steps: dividing a tunnel operation area, obtaining environmental information of a tunnel operation sub-area, analyzing rock drilling difficulty of the tunnel operation sub-area, confirming a tunnel operation trajectory, analyzing conformity of the tunnel operation sub-area, processing an abnormal tunnel operation sub-area, and analyzing health state of a tunnel rock drill. According to the present disclosure, a rock drilling difficulty coefficient of each tunnel operation sub-area is used to analyze a corresponding steel rotating speed, and then the tunnel operation trajectory is confirmed. After the tunnel operation is completed, the operation conformity of each tunnel operation sub-area is analyzed, and each abnormal tunnel operation sub-area is screened out and processed accordingly.Type: GrantFiled: December 13, 2023Date of Patent: July 16, 2024Assignees: CHINA TIESIJU CIVIL ENGINEERING GROUP CO., LTD., ANHUI DIGITAL INTELLIGENT CONSTRUCTION RESEARCH INSTITUTE CO., LTDInventors: Xiaofang Pei, Heng Wang, Xiang Shen, Liang Li, Lina Xiao, Yuefeng Chu, Lulu Tian, Ren Huang, Shouqiang Yin, Hao Liang, Lidong Yang, Di Liu, Jingyi Wu, Xiaoxu Yang, Kuo Zhang, Kaixuan Li
-
Patent number: 9745282Abstract: This invention relates to indoline compounds of the structural formula: or their pharmaceutically acceptable salts, wherein the variables are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase.Type: GrantFiled: June 30, 2016Date of Patent: August 29, 2017Assignees: Merck Sharp & Dohme Corp, ElexoPharm GmbHInventors: Amjad Ali, Michael Man-Chu Lo, Edward Metzger, Lina Yin, Rolf Hartmann, Qingzhong Hu, Ralf Heim, Christina Zimmer
-
Patent number: 9550750Abstract: This invention relates to indo line compounds of the structural formula I, or their pharmaceutically acceptable salts, wherein the variables are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase.Type: GrantFiled: October 2, 2013Date of Patent: January 24, 2017Assignees: Merck Sharp & Dohme Corp., Elexopharm GMBHInventors: Amjad Ali, Michael Man-Chu Lo, Edward Metzger, Lina Yin, Rolf Hartmann, Qingzhong Hu, Ralf Heim, Christina Zimmer
-
Publication number: 20160304486Abstract: This invention relates to indoline compounds of the structural formula: or their pharmaceutically acceptable salts, wherein the variables are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase.Type: ApplicationFiled: June 30, 2016Publication date: October 20, 2016Inventors: Amjad Ali, Michael Man-Chu Lo, Edward Metzger, Lina Yin, Rolf Hartmann, Qingzhong Hu, Ralf Heim, Christina Zimmer
-
Patent number: 9278093Abstract: This invention relates to tricyclic triazole compounds or their pharmaceutically acceptable salts. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the above-cited compounds or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.Type: GrantFiled: March 29, 2013Date of Patent: March 8, 2016Assignees: Merck Sharp & Dohme Corp., ElexoPharm GmbHInventors: Amjad Ali, Emmanuel Bey, Rolf Hartmann, Quingzhong Hu, Lina Yin
-
Publication number: 20150306091Abstract: This invention relates to tricyclic triazole compounds or their pharmaceutically acceptable salts. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the above-cited compounds or their salts as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.Type: ApplicationFiled: March 29, 2013Publication date: October 29, 2015Applicant: Merck Sharp & Dohme Corp.Inventors: Amjad Ali, Emmanuel Bey, Rolf Hartmann, Quingzhong Hu, Lina Yin
-
Publication number: 20150225365Abstract: This invention relates to indo line compounds of the structural formula I, or their pharmaceutically acceptable salts, wherein the variables are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase.Type: ApplicationFiled: October 2, 2013Publication date: August 13, 2015Applicants: ElexoPharm GmbH, Merck Sharp & Dohme Corp.Inventors: Amjad Ali, Michael Man-Chu Lo, Edward Metzger, Lina Yin, Rolf Hartmann, Qingzhong Hu, Ralf Heim, Christina Zimmer
-
Patent number: 9073929Abstract: This invention relates to tricyclic triazole analogs of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.Type: GrantFiled: April 20, 2012Date of Patent: July 7, 2015Assignees: ElexoPharm GmbH, Merck Sharp & Dohme Corp.Inventors: Scott B. Hoyt, Whitney Lane Petrilli, Clare London, Yusheng Xiong, Jerry Andrew Taylor, Amjad Ali, Michael Man-Chu Lo, Timothy J. Henderson, Qingzhong Hu, Rolf Hartmann, Lina Yin, Ralf Heim, Emmanuel Bey, Rohit Saxena, Swapan Kumar Samanta, Bheemashankar A. Kulkarni
-
Publication number: 20140045819Abstract: This invention relates to tricyclic triazole analogues of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.Type: ApplicationFiled: April 20, 2012Publication date: February 13, 2014Applicants: ElexoPharm GmbH, SCHERING CORPORATIONInventors: Scott B. Hoyt, Whitney Lane Petrilli, Clare London, Yusheng Xiong, Jerry Andrew Taylor, Amjad Ali, Michael Man-Chu Lo, Timothy J. Henderson, Qingzhong Hu, Rolf Hartmann, Lina Yin, Ralf Heim, Emmanuel Bey, Rohit Saxena, Swapan Kumar Samanta, Bheemashankar A. Kulkarni